Oppenheimer & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Hold |
1,716
| – | – | 0.01% | 1097 |
|
|
2025
Q1 | $463K | Hold |
1,716
| – | – | 0.01% | 1097 |
|
|
2024
Q4 | $404K | Sell |
1,716
-190
| -10% | -$44.7K | 0.01% | 1149 |
|
|
2024
Q3 | $524K | Buy |
1,906
+190
| +11% | +$52.3K | 0.01% | 1018 |
|
|
2024
Q2 | $417K | Hold |
1,716
| – | – | 0.01% | 1066 |
|
|
2024
Q1 | $256K | Sell |
1,716
-2,663
| -61% | -$398K | ﹤0.01% | 1239 |
|
|
2023
Q4 | $838K | Sell |
4,379
-140
| -3% | -$26.8K | 0.02% | 770 |
|
|
2023
Q3 | $800K | Buy |
4,519
+93
| +2% | +$16.5K | 0.02% | 751 |
|
|
2023
Q2 | $841K | Buy |
4,426
+149
| +3% | +$28.3K | 0.02% | 773 |
|
|
2023
Q1 | $857K | Sell |
4,277
-47
| -1% | -$9.42K | 0.02% | 744 |
|
|
2022
Q4 | $1.03M | Buy |
4,324
+31
| +0.7% | +$7.37K | 0.02% | 671 |
|
|
2022
Q3 | $859K | Sell |
4,293
-763
| -15% | -$153K | 0.02% | 706 |
|
|
2022
Q2 | $738K | Buy |
5,056
+44
| +0.9% | +$6.42K | 0.02% | 790 |
|
|
2022
Q1 | $819K | Buy |
5,012
+2,169
| +76% | +$354K | 0.01% | 819 |
|
|
2021
Q4 | $482K | Buy |
2,843
+504
| +22% | +$85.4K | 0.01% | 1044 |
|
|
2021
Q3 | $441K | Hold |
2,339
| – | – | 0.01% | 1063 |
|
|
2021
Q2 | $397K | Hold |
2,339
| – | – | 0.01% | 1121 |
|
|
2021
Q1 | $331K | Hold |
2,339
| – | – | 0.01% | 1126 |
|
|
2020
Q4 | $304K | Buy |
2,339
+39
| +2% | +$5.07K | 0.01% | 1075 |
|
|
2020
Q3 | $335K | Hold |
2,300
| – | – | 0.01% | 943 |
|
|
2020
Q2 | $341K | Buy |
+2,300
| New | +$341K | 0.01% | 926 |
|